Folgen
Gregory Amidon
Gregory Amidon
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei umich.edu
Titel
Zitiert von
Zitiert von
Jahr
Understanding pharmaceutical quality by design
LX Yu, G Amidon, MA Khan, SW Hoag, J Polli, GK Raju, J Woodcock
The AAPS journal 16, 771-783, 2014
12442014
Physiological Parameters for Oral Delivery and in Vitro Testing
DM Mudie, GL Amidon, GE Amidon
Molecular pharmaceutics 7 (5), 1388-1405, 2010
5062010
Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state
DM Mudie, K Murray, CL Hoad, SE Pritchard, MC Garnett, GL Amidon, ...
Molecular pharmaceutics 11 (9), 3039-3047, 2014
4662014
Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction
CK Tye, CC Sun, GE Amidon
Journal of pharmaceutical sciences 94 (3), 465-472, 2005
4202005
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
Y Tsume, DM Mudie, P Langguth, GE Amidon, GL Amidon
European Journal of Pharmaceutical Sciences 57, 152-163, 2014
3842014
A modified Drucker-Prager Cap model for die compaction simulation of pharmaceutical powders
LH Han, JA Elliott, AC Bentham, A Mills, GE Amidon, BC Hancock
International Journal of Solids and Structures 45 (10), 3088-3106, 2008
3712008
The solubility–permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone
A Dahan, JM Miller, A Hoffman, GE Amidon, GL Amidon
Journal of pharmaceutical sciences 99 (6), 2739-2749, 2010
2362010
Theoretical and experimental studies of transport of micelle‐solubilized solutes
GE Amidon, WI Higuchi, NFH Ho
Journal of pharmaceutical sciences 71 (1), 77-84, 1982
2171982
The solubility–permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation
JM Miller, A Beig, BJ Krieg, RA Carr, TB Borchardt, GE Amidon, ...
Molecular pharmaceutics 8 (5), 1848-1856, 2011
2092011
Particle, powder, and compact characterization
GE Amidon, PJ Secreast, D Mudie
Developing solid oral dosage forms, 163-186, 2009
1862009
Particle size limits to meet USP content uniformity criteria for tablets and capsules
BR Rohrs, GE Amidon, RH Meury, PJ Secreast, HM King, CJ Skoug
Journal of pharmaceutical sciences 95 (5), 1049-1059, 2006
1652006
The effect of moisture on the mechanical and powder flow properties of microcrystalline cellulose
GE Amidon, ME Houghton
Pharmaceutical research 12, 923-929, 1995
1601995
Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs
B Hens, Y Tsume, M Bermejo, P Paixao, MJ Koenigsknecht, JR Baker, ...
Molecular pharmaceutics 14 (12), 4281-4294, 2017
1192017
Mechanistic study of the effect of roller compaction and lubricant on tablet mechanical strength
X He, PJ Secreast, GE Amidon
Journal of pharmaceutical sciences 96 (5), 1342-1355, 2007
1082007
Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus
DM Mudie, Y Shi, H Ping, P Gao, GL Amidon, GE Amidon
Biopharmaceutics & drug disposition 33 (7), 378-402, 2012
1012012
In vivo predictive dissolution: transport analysis of the CO2, bicarbonate in vivo buffer system
BJ Krieg, SM Taghavi, GL Amidon, GE Amidon
Journal of pharmaceutical sciences 103 (11), 3473-3490, 2014
992014
Factors that influence the spontaneous formation of pharmaceutical cocrystals by simply mixing solid reactants
C Maheshwari, A Jayasankar, NA Khan, GE Amidon, ...
CrystEngComm 11 (3), 493-500, 2009
952009
In vivo predictive dissolution: comparing the effect of bicarbonate and phosphate buffer on the dissolution of weak acids and weak bases
BJ Krieg, SM Taghavi, GL Amidon, GE Amidon
Journal of pharmaceutical sciences 104 (9), 2894-2904, 2015
942015
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib
Y Tsume, S Takeuchi, K Matsui, GE Amidon, GL Amidon
European Journal of Pharmaceutical Sciences 76, 203-212, 2015
862015
Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution
S Takeuchi, Y Tsume, GE Amidon, GL Amidon
Journal of pharmaceutical sciences 103 (11), 3416-3422, 2014
842014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20